Other attributes
Company Operating Status
Active
Funding Round Date
December 28, 2020
Investors
No article content yet.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
Application of AI+Immunology for early cancer screening, precision medicine, and next era of biomarker research.